Cutaneous immune-related adverse events in patients with metastatic melanoma on antiprogrammed cell death protein 1 and anticytotoxic T-lymphocyte–associated protein 4 therapy: A r...

by Sheida Naderi-Azad, BSc, Faisal Sickandar, MD, Rossanna C. Pezo, MD, PhD, FRCP
Published 2021-03-01

A systematic review of vitiligo onset and exacerbation in patients receiving biologic therapy

by Muskaan Sachdeva, BHSc, Asfandyar Mufti, MD, Nadia Kashetsky, MSc, Jorge R. Georgakopoulos, MD, Sheida Naderi-Azad, BSc, Jennifer Salsberg, MD, FRCPC, Jensen Yeung, MD, FRCPC
Published 2021-03-01